Publications by authors named "Mengxing Xue"

Claim this Profile
V
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML.
Jing Lu, Sheng-Li Xue, Ying Wang, Xue-Feng He, Xiao-Hui Hu, Meng-Xing Xue, Xue-Qing Dou

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rare ZMYND8::PDGFRβ Fusion Transcript in Acute Lymphoblastic Leukemia.
Ailing Deng, Man Wang, Dongyun Jiang, Jiannong Cen, Mengxing Xue, Xueqing Dou

Int J Lab Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artichoke water extract protects against Lead-induced hepatotoxicity by activating Nrf2 signaling and inhibiting NLRP3/caspase-1/GSDMD-mediated pyroptosis.
Aihua Deng, Mengyuan Yi, Yun Wang, Ping Mo, Kerui Huang, Mengxing Xue

J Ethnopharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel KMT2A::DCP1A fusion gene in acute myeloid leukemia.
Ailing Deng, Fenghong Zhang, Man Wang, Dongyun Jiang, Jiannong Cen, Mengxing Xue, Xueqing Dou

Leuk Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD.
Jing Lu, Yu Zhu, Huiying Qiu, Ying Wang, Xin Zhou, Mengxing Xue, Xueqing Dou

Discov Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful combined venetoclax to PD-1 blockade and ruxolitinib for refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Yue Song, Xiaofei Yang, Qian Wu, Mengxing Xue, Fei Zhou, Xuefeng He

Br J Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial.
Jing Lu, Huiying Qiu, Ying Wang, Xin Zhou, Haiping Dai, Mengxing Xue, Xueqing Dou

J Hematol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation.
Jiayu Huang, Bingyang Shi, Suhui Yu, Mengxing Xue, Ling Wang

Blood Cancer J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia.
Qian Wu, Xiaofei Yang, Jingren Zhang, Mengxing Xue, Xueqing Dou, Xuemei Sun

Blood Cancer J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and clinical implications of recurrent PAX5::MLLT3 fusion in lymphoid blastic phase chronic myeloid leukemia.
Lijun Wang, Yu Chen, Qingyuan Wang, Meng Xiang, Zhao Zeng, Mengxing Xue

Int J Lab Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation.
Fei Zhou, Feng Du, Ziyan Wang, Mengxing Xue, Depei Wu, Xuefeng He

J Hematol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia.
Yilin Chen, Na Xu, Yunfan Yang, Zhenfang Liu, Mengxing Xue

Cancer Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights from a rare myeloproliferative neoplasm with coexisting fusion gene, and mutations treated with nilotinib and ruxolitinib.
Li Huo, Jundan Xie, Qian Wang, Hongjie Shen, Zixuan Ding, Mengxing Xue

Clin Case Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients.
Jiaqi Tan, Mengxing Xue, Jinlan Pan, Jiannong Cen, Xiaomei Qi

Acta Haematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts.
Mengxing Xue, Qinrong Wang, Li Huo, Lijun Wen, Xiaofei Yang

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatments.
Guangying Sheng, Mengxing Xue, Qinrong Wang, Lijun Wen, Suning Chen

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients.
Sheng-Li Xue, Hong-Xia Cui, Jing-Ying Zou, Meng-Xing Xue, Xiao-Wen Tang

Hematol Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of interleukin-15 polymorphisms in adult acute lymphoblastic leukemia.
Dandan Lin, Chunliang Liu, Mengxing Xue, Rengyun Liu, Lan Jiang

PLoS One· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia with T315I mutation after haplo-identical hematopoietic stem cell transplantation with donor lymphocyte transfusion and interferon-alpha-2b.
Ying Wang, Meng-Xing Xue, Xiao-Hui Wu, Xiao-Wen Tang, Ai-Ning Sun

Leuk Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].
Meng-xing Xue, Hui-ying Qiu, Yu-feng Feng, Zi-ling Zhu, Wei-rong Chang, Yong-quan Xue

Zhonghua Xue Ye Xue Za Zhi· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis